Six minute walk test in COPD – Comparison with spirometry Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010
Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1 Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016
Re-assessing the importance of FEV1 decline Source: Eur Respir Monogr 2015; 69: 134-142 Year: 2015
Peak expiratory flow monitoring – Optimal criterion for diagnosis of professional asthma? Source: Annual Congress 2011 - The work environment in the clinic Year: 2011
Managing asthma in the outpatient clinic – Can the FEV1/FVC indicate when to do a reversibility test? Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Methacholine challenges for detection of bronchial hyperresponsiveness (BHR) – a comparison of forced spirometry and body plethysmography Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Predicted spirometric values for Romanian adults – A preliminary study Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Spirometry of pre-school children – time for new reference values? Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease Year: 2009
Natural decline in FEV1 and FVC: Self versus reference equations Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Lung function study in Madagascan children: Spirometric reference values and prevalence of bronchial asthma – The VAVANY-study Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010
1 year RV/TLC change as a predictor of long term decline of FEV1 Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2011 - COPD diagnosis Year: 2011
Six minute walk test (6MWT) in patients with diagnosis of lung cancer – Clinical value in physiological evaluation candidates for surgical treatment Source: Annual Congress 2012 - Pre-operative evaluation in thoracic surgery Year: 2012
The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Spirometry and impulse oscillometry in preschool children – comparison to common reference values Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease Year: 2009
Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
FEV1 and sRaw in bronchial challenge testing, exchangeable or supplementaFEV1 and sRaw in bronchial challenge testing, exchangeable or supplemental? Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015